Summary of "Drug Testing State of the Union 2025"

Webinar Overview

The "Drug Testing State of the Union 2025" webinar, hosted by Ashley Kirchart and featuring Dr. Todd Simo, Chief Medical Officer at Higher Right, presents a comprehensive overview of drug testing trends, policies, and practices as they stand in 2025.

Key Points Discussed

Trends in Drug Testing: Dr. Simo emphasizes the importance of understanding the lab positive rates for drug screening, particularly focusing on marijuana (Delta 9 THC) as an illicit substance. He references data from Quest Diagnostics to illustrate national trends in drug use, noting that marijuana remains a significant concern despite evolving regulations.
Medical Review Officer (MRO) Insights: A significant portion of laboratory positives (about one-third) are overturned during medical review, highlighting the importance of MROs in interpreting drug test results. The MRO's report is deemed more relevant than initial lab results for employers.
Specimen Utilization: The webinar discusses the different specimens used for drug testing, with urine being the most common. However, there is a noted shift toward Oral Fluid Testing, especially in states with changing marijuana laws. Dr. Simo advocates for the inclusion of THC in testing panels, particularly for safety-sensitive positions.
Regulatory Landscape: The evolving legal landscape around marijuana use is addressed, with Dr. Simo outlining the need for employers to adapt their drug testing policies according to state laws, particularly in states that have legalized marijuana for medical or recreational use. He stresses the importance of having clear policies regarding THC testing and employee accommodations.
Return on Investment (ROI): The financial implications of drug testing are discussed, with data showing that removing illicit drug users from the workforce can save organizations significant amounts of money annually. Oral Fluid Testing is highlighted as having a high ROI due to its effectiveness in detecting recent drug use.
Recommendations for Employers: Dr. Simo provides practical recommendations for employers, such as developing explicit drug-free workplace policies, training staff on reasonable suspicion identification, and considering point-of-collection testing to streamline the drug screening process.
Conclusion: The session concludes with an emphasis on the need for employers to stay informed and proactive regarding drug testing policies and practices to ensure workplace safety and compliance with legal standards.